Literature DB >> 22084017

Longitudinal analysis of voice quality in patients with early glottic cancer after transoral laser microsurgery.

Pen-Yuan Chu1, Yen-Bin Hsu, Tsung-Lun Lee, Sherry Fu, Li-Mei Wang, Ya-Chung Kao.   

Abstract

BACKGROUND: We conducted longitudinal voice evaluations in patients with early glottic cancer who underwent transoral laser microsurgery (TLM) to determine the time to stability.
METHODS: Twenty-five patients underwent TLM, including 13 limited cordectomies (type I and type II) and 12 extended cordectomies (type III to type IV). Multidimensional voice evaluations were performed before treatment and at 1, 3, 6, and 12 months after treatment.
RESULTS: Voice parameters of asthenicity, strain, mean airflow rate (MFR), voice handicap index (VHI)-functional, VHI-physical, and VHI-total scores improved in all patients. Most patients had improved 6 months after TLM. Patients with extended cordectomy showed higher breathiness, MFR, VHI-functional, and VHI-total scores. Healing was complete in all cases by 6 months and in a majority of cases (76%) by 3 months.
CONCLUSIONS: Voice quality achieved stability 6 months after TLM. Comparing treatment outcomes and surgical intervention are not recommended within 6 months of surgery.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22084017     DOI: 10.1002/hed.21914

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

Review 1.  Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.

Authors:  Matthew T Greulich; Noah P Parker; Philip Lee; Albert L Merati; Stephanie Misono
Journal:  Otolaryngol Head Neck Surg       Date:  2015-04-02       Impact factor: 3.497

2.  Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery.

Authors:  Pei-Ju Chien; Li-Ting Hung; Ling-Wei Wang; Muh-Hwa Yang; Pen-Yuan Chu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-06       Impact factor: 2.503

3.  Effect of resection depth of early glottic cancer on vocal outcome: an optimized finite element simulation.

Authors:  Ted Mau; Anil Palaparthi; Tobias Riede; Ingo R Titze
Journal:  Laryngoscope       Date:  2015-05-22       Impact factor: 3.325

4.  Predictors of Six-month Change in the Voice Handicap Index in a Treatment-seeking Population.

Authors:  Jaime Moore; Caprice Greenberg; Susan L Thibeault
Journal:  J Voice       Date:  2016-03-04       Impact factor: 2.009

5.  Oncological Outcomes Following Transoral CO2 Laser Microsurgery for T1 Glottic Cancer.

Authors:  Ankur Batra; A Goyal; M Goyal; S Goel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-14

Review 6.  Transoral Laser Microsurgery in Early Glottic Lesions.

Authors:  E V Sjögren
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-03-11

7.  Single Stage Transoral Laser Microsurgery for Early Glottic Cancer.

Authors:  Yaniv Hamzany; Hagit Shoffel-Havakuk; Stav Devons-Sberro; Shani Shteinberg; Dan Yaniv; Aviram Mizrachi
Journal:  Front Oncol       Date:  2018-08-14       Impact factor: 6.244

8.  Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year.

Authors:  Yda van Loon; Martine Hendriksma; Bas J Heijnen; Vivienne A H van de Kamp; Marieke M Hakkesteegt; Stefan Böhringer; Ton P M Langeveld; M A de Jong; W Martin C Klop; Robert J Baatenburg de Jong; Elisabeth V Sjögren
Journal:  Head Neck       Date:  2019-01-16       Impact factor: 3.147

Review 9.  Voice quality after transoral CO2 laser microsurgery (TOLMS): systematic review of literature.

Authors:  Andrea Colizza; Massimo Ralli; Chiara D'Elia; Antonio Greco; Marco de Vincentiis
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-05-03       Impact factor: 3.236

10.  T1a Glottic Cancer: Advances in Vocal Outcome Assessment after Transoral CO2-Laser Microsurgery Using the VEM.

Authors:  Wen Song; Felix Caffier; Tadeus Nawka; Tatiana Ermakova; Alexios Martin; Dirk Mürbe; Philipp P Caffier
Journal:  J Clin Med       Date:  2021-03-17       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.